Association of Hb F Level With Clinical Severity of Beta Thalassemia
Sponsored by Nanfang Hospital, Southern Medical University
About this trial
Last updated 4 years ago
Study ID
HbF-Beta thalassemia
Status
Recruiting
Type
Observational
Placebo
No
Accepting
All
All
Not accepting
Healthy Volunteers
Trial Timing
Started 6 years ago
What is this trial about?
The production of Hb F after birth is an important factor in modifying the clinical severity
of beta thalassemia because an increased gamma-globin level will bind the additional a-globin
and form Hb F. The objective of this project is to evaluate the association of Hb F level
with phenotypic diversity of patients with beta thalassemia.
What are the participation requirements?
Inclusion Criteria
- Diagnosed with beta-thalassemia
Exclusion Criteria
- Iron Deficiency Anemia
Locations
Location
Status
Recruiting